SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Brittney Yegla, Vinay Parikh, Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects, Frontiers in Systems Neuroscience, 2015, 8,

    CrossRef

  2. 2
    Elise Demeter, Martin Sarter, Leveraging the cortical cholinergic system to enhance attention, Neuropharmacology, 2013, 64, 294

    CrossRef

  3. 3
    R. Lopes, L. Fernandes, Bipolar Disorder: Clinical Perspectives and Implications with Cognitive Dysfunction and Dementia, Depression Research and Treatment, 2012, 2012, 1

    CrossRef

  4. 4
    Giana de P. Cognato, Josiane W. Bortolotto, Ana R. Blazina, Raíssa R. Christoff, Diogo R. Lara, Mônica R. Vianna, Carla D. Bonan, Y-Maze memory task in zebrafish (Danio rerio): The role of glutamatergic and cholinergic systems on the acquisition and consolidation periods, Neurobiology of Learning and Memory, 2012, 98, 4, 321

    CrossRef

  5. 5
    Paul Bentley, Jon Driver, Raymond J. Dolan, Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging, Progress in Neurobiology, 2011, 94, 4, 360

    CrossRef

  6. 6
    Michael E Hasselmo, Martin Sarter, Modes and Models of Forebrain Cholinergic Neuromodulation of Cognition, Neuropsychopharmacology, 2011, 36, 1, 52

    CrossRef

  7. 7
    Julie A. Dumas, Brenna C. McDonald, Andrew J. Saykin, Thomas W. McAllister, Mary L. Hynes, John D. West, Paul A. Newhouse, Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women, Menopause, 2010, 17, 4, 852

    CrossRef

  8. 8
    Olivier Blin, Christine Audebert, Séverine Pitel, Arthur Kaladjian, Catherine Casse-Perrot, Mohammed Zaim, Joelle Micallef, Jacky Tisne-Versailles, Pierre Sokoloff, Philippe Chopin, Marc Marien, Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies, Psychopharmacology, 2009, 207, 2, 201

    CrossRef

  9. 9
    Joseph F Goldberg, KN Roy Chengappa, Identifying and treating cognitive impairment in bipolar disorder, Bipolar Disorders, 2009, 11,
  10. 10
    Elizabeth Scarr, Brian Dean, Role of the cholinergic system in the pathology and treatment of schizophrenia, Expert Review of Neurotherapeutics, 2009, 9, 1, 73

    CrossRef

  11. 11
    P. M. Greenwood, M.-K. Lin, R. Sundararajan, K. J. Fryxell, R. Parasuraman, Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory, Proceedings of the National Academy of Sciences, 2009, 106, 9, 3633

    CrossRef

  12. 12
    Julie A. Dumas, Andrew J. Saykin, Brenna C. McDonald, Thomas W. McAllister, Mary L. Hynes, Paul A. Newhouse, Nicotinic Versus Muscarinic Blockade Alters Verbal Working Memory-Related Brain Activity in Older Women, The American Journal of Geriatric Psychiatry, 2008, 16, 4, 272

    CrossRef

  13. 13
    Current awareness in human psychopharmacology, Human Psychopharmacology: Clinical and Experimental, 2005, 20, 2